News

Vasogen Selects Clinivation’s Clinical, Regulatory, Design and Quality Assurance Solutions

Innovative developer of therapies targeting inflammation accelerates growth with clinivation’s clinical, regulatory, design, and quality assurance solutions. Framingham, MA, January 12, 2007 – clinivation, Inc. announced today that Vasogen, Inc. (NASDAQ CM: VSGN) has selected clinivation’s clinical, regulatory, design and…

Read MoreVasogen Selects Clinivation’s Clinical, Regulatory, Design and Quality Assurance Solutions

Biocompatibles International Selects Clinivation WorldView for On-Demand Global Regulatory Intelligence

Emerging leader in drug device combination products selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide. Framingham, MA, December 18, 2006 – clinivation, Inc. announced today that Biocompatibles International plc (LSE:…

Read MoreBiocompatibles International Selects Clinivation WorldView for On-Demand Global Regulatory Intelligence

Clinivation Founder and CEO Joseph Kozikowski, M.D. to Present at Philips Research Global Headquarters Eindhoven High Tech Campus

Dr. Joseph Kozikowski will present on the use of nanoscale molecular imaging in translational medicine at Philips research global headquarters. FRAMINGHAM, MA – December 1, 2006 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will…

Read MoreClinivation Founder and CEO Joseph Kozikowski, M.D. to Present at Philips Research Global Headquarters Eindhoven High Tech Campus